If youre thinking about adding a GLP-1 medication to your plan, see if you qualify for Noom Med
Genotoxicity replicability varied between 23% and 78% depending on the test guideline
The use of GLP-1 agonists has been associated with a reduced incidence of glaucoma in diabetic patients (80)
Treatment-related factors: antipsychotics, weight gain, GLP-1 receptor agonists, ketogenic diet, bariatric surgery
Food and Drug Administration late last month updated its warning label for Ozempic, saying that the drug may lead to ileus, a condition in which the intestines dont work correctly
Other licensed weight loss medications Retatrutide, although still undergoing clinical trials, will likely have once weekly injection dosing as similar to Mounjaro and Wegovy